Home
About
Overview
Sharing Data
ORCID
Help
History (64)
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.
[Dynamic pathway modeling language: CSML].
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
Rhinitis, Atrophic
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
See All 64 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. N Engl J Med. 2020 09 03; 383(10):931-943.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Edema
Exons
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Piperidines
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Pyridazines
Pyrimidines
authors with profiles
Marina Chiara Garassino